한글목차

세계 마이크로바이옴 시퀀싱 시장 규모는 2024년 15억 달러에서 2029년 말에는 37억 달러로 확대될 것으로 예상되며, 2024년부터 2029년까지 19.3%의 CAGR을 기록할 것으로 예측됩니다.

북미 시장 규모는 2024년 5억 3,980만 달러에서 2029년 말 12억 달러로 확대될 것으로 예상되며, 같은 기간 CAGR은 17.6%로 추정됩니다.

유럽 시장 규모는 2024년 4억 4,450만 달러에서 2029년 말 11억 달러로 확대될 것으로 예상되며, 같은 기간 CAGR은 20.0%로 예측됩니다.

세계의 마이크로바이옴 시퀀싱 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 신흥 기술 및 기술 개발 동향, 시장 규모 추정과 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 개요
• 전망
• 거시경제 분석
• 미중 무역전쟁의 영향

제3장 시장 역학

• 시장 성장 촉진요인
• 유전체당 비용 절감
• 정부 이니셔티브와 자금
• 시퀀싱 기술의 진보
• 시장 성장 억제요인
• 데이터의 복잡성과 바이오인포매틱스 과제
• 표준화된 프로토콜과 참조 데이터베이스의 결여
• 조성금의 부족
• 시장 기회
• 맞춤형 의료와 진단
• 의약품 발견과 개발
• 농업과 식품 산업

제4장 규제 상황

• 개요

제5장 신기술과 특허 분석

• 신기술
• 나노포어 시퀀싱
• SMRT 시퀀싱
• 마이크로플루이딕스를 이용한 FACS
• 메타전사체 시퀀싱
• 특허 분석
• 지역 패턴

제6장 시장 부문 분석

• 시장 동향
• 세분화 내역
• 마이크로바이옴 시퀀싱 : 세계 시장
• 시장 분석 : 시퀀싱 기술별
• 하이 스루풋 시퀀싱
• 생어 시퀀싱
• 제3세대 시퀀싱
• 시장 분석 : 구성요소별
• 시약·키트
• 기기
• 시장 분석 : 연구실 유형별
• 웨트 실험실
• 드라이 실험실
• 시장 분석 : 용도별
• 질환 진단 연구
• 맞춤형 의료
• Drug Discovery
• 유전자 검사
• 기타
• 시장 분석 : 최종사용자별
• 제약·바이오테크놀러지
• 학술 센터·연구기관
• 기타
• 지역적 내역
• 시장 내역 : 지역별
• 북미
• 유럽
• 아시아태평양
• 중동 및 아프리카
• 남미

제7장 경쟁 구도

• 주요 공급업체 및 제조업체
• 마이크로바이옴 시퀀싱 업계 기업 순위
• 전략 분석

제8장 환경, 사회, 지배구조(ESG) 관점

• 마이크로바이옴 시퀀싱 시장의 지속가능성
• ESG 리스크와 등급설정 : 데이터 이해
• BCC에 의한 결론

제9장 부록

• 조사 방법
• 정보 출처
• 약어
• 기업 개요
• BASECLEAR BV
• CD GENOMICS
• CHARLES RIVER LABORATORIES
• COSMOSID
• CROWN BIOSCIENCE
• DANAHER CORP.
• EUROFINS SCIENTIFIC
• ILLUMINA INC.
• MERIEUX NUTRISCIENCES
• MICROBIOME INSIGHTS
• NOVOGENE CO. LTD.
• OXFORD NANOPORE TECHNOLOGIES PLC
• PACBIO
• QIAGEN
• THERMO FISHER SCIENTIFIC INC.
• Emerging Startups
• Pendulum
• Microba
• Biomesense

영문목차

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

The North American microbiome sequencing market is expected to grow from $539.8 million in 2024 and is projected to reach $1.2 billion by the end of 2029, at a CAGR of 17.6% during the forecast period of 2024 to 2029.

The European microbiome sequencing market is expected to grow from $444.5 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 20.0% during the forecast period of 2024 to 2029.

Report Scope

The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user, offering insights into key trends and growth drivers. The study concludes with an analysis of leading companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period.

This report analyzes the macroeconomic factors affecting the market. Market drivers, restraints and opportunities are identified. The report covers the regulatory landscape, recent technologies and patents in the market, as well as innovations in products and performance. The report also covers the competitive landscape, ESG factors and profiles of leading companies.

Regional analysis covers North America (U.S., Canada and Mexico), Europe (U.K., Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Middle East and Africa (MEA) and South America (Brazil, Argentina and Rest of South America).

Report Includes

• 50 data tables and 51 additional tables
• Analyses of the global market trends for microbiome sequencing technologies, with revenue data from 2021-2024, and projected CAGRs through 2029
• Estimates of the size and revenue prospects for the global market, along with a market share analysis by sequencing technology, component, laboratory type, application, end user and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• A look at the emerging trends and opportunities in microbiome-based therapeutics, clinical trials
• Evaluation of recent patent activity and key granted and published patents
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies including Illumina Inc., Qiagen, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Plc., and PacBio.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Outlook
• Macroeconomic Analysis
• Impact of U.S.-China Trade War

Chapter 3 Market Dynamics

• Market Drivers
• Decreasing Cost per Genome
• Government Initiatives and Funding
• Advances in Sequencing Technology
• Market Restraints
• Data Complexity and Bioinformatics Challenges
• Lack of Standardized Protocols and Reference Databases
• Lack of Grant Funding
• Market Opportunities
• Personalized Medicine and Diagnostics
• Drug Discovery and Development
• Agriculture and the Food Industry

Chapter 4 Regulatory Landscape

• Overview

Chapter 5 Emerging Technologies and Patent Analysis

• Emerging Technologies
• Nanopore Sequencing
• SMRT Sequencing
• FACS with Microfluidics
• Metatranscriptome Sequencing
• Patent Analysis
• Regional Patterns

Chapter 6 Market Segment Analysis

• Market Trends
• Segmentation Breakdown
• Microbiome Sequencing: Global Markets
• Market Analysis by Sequencing Technology
• High-throughput Sequencing
• Sanger Sequencing
• Third-Generation Sequencing
• Market Analysis by Component
• Reagents and Kits
• Instruments
• Market Analysis by Laboratory Type
• Wet Labs
• Dry Labs
• Market Analysis by Application
• Disease Diagnosis Research
• Personalized Medicine
• Drug Discovery
• Genetic Screening
• Other Applications
• Market Analysis by End User
• Pharmaceutical and Biotechnology
• Academic Centers and Research Institutes
• Other End Users
• Geographic Breakdown
• Market Breakdown by Region
• North America
• Europe
• Asia-Pacific
• MEA
• South America

Chapter 7 Competitive Landscape

• Key Suppliers and Manufacturers
• Ranking of Companies in the Microbiome Sequencing Industry
• Strategic Analysis

Chapter 8 Environmental, Social, and Governance (ESG) Perspective

• Sustainability in the Microbiome Sequencing Market
• ESG Risks and Ratings: Understanding the Data
• BCC Research Viewpoint

Chapter 9 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• BASECLEAR BV
• CD GENOMICS
• CHARLES RIVER LABORATORIES
• COSMOSID
• CROWN BIOSCIENCE
• DANAHER CORP.
• EUROFINS SCIENTIFIC
• ILLUMINA INC.
• MERIEUX NUTRISCIENCES
• MICROBIOME INSIGHTS
• NOVOGENE CO. LTD.
• OXFORD NANOPORE TECHNOLOGIES PLC
• PACBIO
• QIAGEN
• THERMO FISHER SCIENTIFIC INC.
• Emerging Startups
• Pendulum
• Microba
• Biomesense